Brazil’s CFBM Defines Biomedical Roles in Medical and Scientific Cannabis, Not General Prescribing Authority
CFBM Resolution 427 defines qualified biomedical roles in cannabis analysis, quality control, research, pharmacovigilance and technical responsibility. It does not permit autonomous prescribing of medicines reserved for physicians or dentists. It took effect on August 11, not in October.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
in.gov.br
CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.
Original Link
https://www.in.gov.br/web/dou/-/resolucao-cfbm-n-427-de-10-de-agosto-de-2026-724475557